Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C4GX
|
|||
| Former ID |
DIB008278
|
|||
| Drug Name |
GBL-310
|
|||
| Synonyms |
Anti-hyperproliferative (topical, actinic keratosis), Grannus
Click to Show/Hide
|
|||
| Indication | Keratosis [ICD-11: ED56; ICD-10: L57.0] | Phase 2 | [1] | |
| Company |
Grannus BioSciences Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mitogen-activated protein kinase (MAPK) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025788) | |||
| REF 2 | WO patent application no. 2010,0456,51, Methods for analyzing drug response. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.